Direct and indirect costs of osteoarthritis in Singapore: A comparative study among multiethnic Asian patients with osteoarthritis

Journal of Rheumatology

Volumn 34, Issue 1, 2007, Pages 165-171

  Xie, Feng ^a   Thumboo, Julian ^b,c   Fong, Kok Yong ^b,c   Lo, Ngai Nung ^c   Yeo, Seng Jin ^c   Yang, Kuang Ying ^c   Li, Shu Chuen ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Asia; Costof illness; Ethnic group; Osteoarthritis; Singapore

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; COST OF ILLNESS; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; JOINT SURGERY; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; SINGAPORE; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; INDIA; MALAYSIA; MALE; MIDDLE AGED; OSTEOARTHRITIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SINGAPORE;

EID: 33846204811     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. March LM, Bachmeier CJM. Economic of osteoarthritis: a global perspective. Baillieres Clin Rheumatol 1997;11:817-34.
2. Woo J, Lau E, Lau CS, et al. Socioeconomic impact of osteoarthritis in Hong Kong: utilization of health and social services, and direct and indirect costs. Arthritis Rheum 2003;49:526-34.
3. Centers for Disease Control and Prevention. Direct and indirect costs of arthritis and other rheumatic conditions - United States, 1997. MMWR Morb Mortal Wkly Rep 2003;52:1124-7.
4. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Direct medical costs unique to people with arthritis. J Rheumatol 1997;24:719-25.
5. Lanes SF, Lanza LL, Radensky PW, et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum 1997;40:1475-81.
6. Leardini G, Salaffi F, Caporali R, Canesi B, Rovati L, Montanelli R. Direct and indirect costs of osteoarthritis of the knee. Clin Exp Rheumatol 2004;22:699-706.
7. Liang MH, Larson M, Thompson M, et al. Costs and outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1984;27:522-9.
8. MacLean CH, Knight K, Paulus H, Brook RH, Shekelle PG. Costs attributable to osteoarthritis. J Rheumatol 1998;25:2213-8.
9. Felts W, Yelin E. The economic impact of the rheumatic diseases in the United States. J Rheumatol 1989;16:867-84.
10. Yelin E, Cisternas MG, Pasta DJ, Trupin L, Murphy L, Helmick CG. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates. Arthritis Rheum 2004;50:2317-26.
11. Satkunananthan K. Musculoskeletal disorders. Singapore Fam Physician 2003;29:14-6.
12. Yoshida S, Aoyagi K, Felson DT, Aliabadi P, Shindo H, Takemoto T. Comparison of the prevalence of radiographic osteoarthritis of the knee and hand between Japan and the United States. J Rheumatol 2002;29:1454-8.
13. Zhang Y, Xu L, Nevitt MC, et al. Comparison of the prevalence of knee osteoarthritis between the elderly Chinese population in Beijing and whites in the United States: The Beijing Osteoarthritis Study. Arthritis Rheum 2001;44:2065-71.
14. Haq SA, Darmawan J, Islam MN, et al. Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol 2005;32:348-53.
15. Minh Hoa TT, Darmawan J, Chen SL, Van Hung N, Thi NC, Ngoc AT. Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study. J Rheumatol 2003;30:2252-6.
16. Department of Statistics. Yearbook of statistics Singapore. Singapore: Department of Statistics, Ministry of Trade & Industry, Republic of Singapore; 2005.
17. Luce BR, Manning WG, Siegel JE, Lipscomb J. Estimating costs in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell JE, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996:176-213.
18. Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation of costs: the Dutch manual for costing in economic evaluations. Pharmacoeconomics 2002;20:443-54.
19. Mittendorf T, Merkesdal S, Huelsemann JL, der Schulenburg JM, Zeidler H, Ruof J. Implementing standardized cost categories within economic evaluations in musculoskeletal diseases. Eur J Health Econ 2003;4:43-9.
20. Lubeck DP, Yelin EH. A question of value: measuring the impact of chronic disease. Milbank Q 1988;66:444-64.
21. Lubeck DP. The costs of musculoskeletal disease: health needs assessment and health economics. Best Pract Res Clin Rheumatol 2003;17:529-39.
22. Liljas B. How to calculate indirect costs in economic evaluations. Pharmacoeconomics 1998;13:1-7.
23. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. J Rheumatol 1997;24:43-8.
24. Dominick KL, Baker TA. Racial and ethnic differences in osteoarthritis: prevalence, outcomes, and medical care. Ethnic Dis 2004;14:558-66.
25. Dominick KL, Bosworth HB, Jeffreys AS, Grambow SC, Oddone EZ, Horner RD. Racial/ethnic variations in non-steroidal anti-inflammatory drug (NSAID) use among patients with osteoarthritis. Pharmacoepidemiol Drug Saf 2004;13:683-94.
26. Escalante A, Espinosa-Morales R, del Rincon I, Arroyo RA, Older SA. Recipients of hip replacement for arthritis are less likely to be Hispanic, independent of access to health care and socioeconomic status. Arthritis Rheum 2000;43:390-9.
27. Hawker GA. The quest for explanations for race/ethnic disparity in rates of use of total joint arthroplasty. J Rheumatol 2004;31:1683-5.
28. Ibrahim SA, Siminoff LA, Burant CJ, Kwoh CK. Understanding ethnic differences in the utilization of joint replacement for osteoarthritis: the role of patient-level factors. Med Care 2002;40:I44-I51.
29. Jones A, Kwoh CK, Kelley ME, Ibrahim SA. Racial disparity in knee arthroplasty utilization in the Veterans Health Administration. Arthritis Rheum 2005;53:979-81.
30. Oishi CS, Hoaglund FT, Gordon L, Ross PD. Total hip replacement rates are higher among Caucasians than Asians in Hawaii. Clin Orthop Rel Res 1998;166-74.
31. Olson JC, Poland J. Tracking racial and ethnic disparities of knee replacement rates in Connecticut. Conn Med 2005;69:211-5.
32. Skinner J, Weinstein JN, Sporer SM, Wennberg JE. Racial, ethnic, and geographic disparities in rates of knee arthroplasty among Medicare patients. N Engl J Med 2003;349:1350-9.
33. Suarez-Almazor ME, Souchek J, Kelly PA, et al. Ethnic variation in knee replacement: patient preferences or uninformed disparity? Arch Intern Med 2005;165:1117-24.
34. Le Pen C, Reygrobellet C, Gerentes I. Financial cost of osteoarthritis in France. The "COART" France study. Joint Bone Spine 2005;72:567-70.
35. Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis 2004;63:395-401.
36. Gupta S, Hawker GA, Laporte A, Croxford R, Coyte PC. The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatology Oxford 2005;44:1531-7.